Evidence map›Paper›PMID 41609128›Full record

ReviewJournal of travel medicine2026

Time requirements of pre-acclimatization at simulated altitude to prevent acute mountain sickness.

Johannes Burtscher, Katharina Hüfner, Hannes Gatterer, Jacqueline Pichler-Hefti, Urs Hefti, Markus Tannheimer, Axel Kleinsasser, Peter Hackett, Martin Burtscher

Abstract readReview
In one paragraph

Review in Journal of travel medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Johannes BurtscherDepartment of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
Katharina HüfnerDepartment of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital for Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
Hannes GattererInstitute of Mountain Emergency Medicine, Eurac Research, Bolzano, Italy.
Jacqueline Pichler-HeftiSwiss Sportclinic, Bern, Switzerland.
Urs HeftiSwiss Sportclinic, Bern, Switzerland.
Markus TannheimerDepartment of Sport and Rehabilitation Medicine, Department of General and Visceral Surgery, University of Ulm, ADK-Klinik Blaubeuren, Germany.ORCID 0000-0001-7830-6470
Axel KleinsasserDepartment of Anaesthesiology & Critical Care Medicine, Innsbruck Medical University, Innsbruck, Austria.
Peter HackettDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Martin BurtscherDepartment of Sport Science, University of Innsbruck, Innsbruck, Austria.ORCID 0000-0002-5232-3632

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTravelling to high altitudes (sleeping above 2500 m) carries a risk of acute mountain sickness (AMS). Proper pre-acclimatization strategies, such as time spent at simulated altitude, can significantly lower this risk. However, the optimal duration of pre-acclimatization remains unknown. Therefore, we examined published research on how different types and durations of pre-acclimatization at simulated altitude influence the AMS risk.

methodsA literature search was conducted to find controlled studies investigating the effects of normobaric or hypobaric simulated altitude exposures. Inclusion criteria required sufficient details on study design, exposure duration and outcomes, specifically the incidence of AMS on subsequent ascent. The simulated or real altitude exposure following pre-acclimatization had to last at least eight hours to accurately assess AMS incidence.

resultsFindings from seven controlled studies using repeated intermittent exposures to simulated altitude were included. The cumulative pre-acclimatization time ranged from 7 to 104 hours; altitudes ranged from 2200 to 5000 m. The AMS risk after pre-acclimatization decreased by 12-73% compared to controls, with the degree of reduction depending mainly on the duration at simulated altitude. Extrapolating from these data indicates that, within the analysed altitude range, ~200 hours of pre-acclimatization may reduce the subsequent AMS risk to nearly zero.

conclusionsOur analysis suggests that accumulating 200 hours in a hypoxic simulated-altitude environment substantially reduces the risk of AMS when subsequently exposed to terrestrial altitude. The effectiveness of this strategy depends on the intervals between pre-acclimatization exposures, the method used and the target altitude. Observational studies indicate that time spent at simulated altitude can be complemented by time spent at terrestrial altitude. Importantly, while pre-acclimatization exposures can effectively prevent AMS, they do not, per se, enhance endurance performance or mountaineering skills, and factors such as co-existing mental or physical health conditions may influence risk and the effectiveness of prevention.

Indexed as

AcclimatizationAltitudeAltitude SicknessTravelAcute DiseaseHumansTime Factorsacute mountain sicknessaltitudehypobaricHypoxianormobaricpre-acclimatization

Identifiers

PMID41609128
PMCPMC13042220

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.